T1International

File:T1International logo.png

T1International logo

T1International is a global advocacy organization focused on addressing the challenges faced by individuals living with Type 1 diabetes. The organization is dedicated to ensuring access to affordable and equitable care for all people with Type 1 diabetes worldwide.

Mission and Vision

T1International's mission is to advocate for people with Type 1 diabetes by supporting local communities and influencing global policy. The organization envisions a world where everyone with Type 1 diabetes has access to the medicine and care they need to survive and thrive.

History

T1International was founded in 2013 by Elizabeth Rowley, who recognized the need for a global movement to address the disparities in diabetes care. The organization has since grown to include a network of advocates and volunteers from around the world.

Activities

T1International engages in a variety of activities to support its mission:

Advocacy

The organization works to influence policy at both the national and international levels. It collaborates with governments, healthcare providers, and other stakeholders to promote policies that improve access to insulin and diabetes care.

Community Support

T1International supports local advocacy groups and provides resources to empower individuals to advocate for their own needs. The organization offers training and tools to help communities organize and campaign effectively.

Education

The organization provides educational resources to raise awareness about Type 1 diabetes and the challenges faced by those living with the condition. T1International aims to educate the public, healthcare professionals, and policymakers about the importance of access to insulin and diabetes care.

Global Impact

T1International has made significant strides in raising awareness about the global insulin crisis. The organization has been instrumental in highlighting the high cost of insulin and the impact of this on individuals with Type 1 diabetes, particularly in low- and middle-income countries.

Challenges

Despite its successes, T1International faces several challenges, including:

• The high cost of insulin and diabetes supplies.
• Disparities in healthcare access across different regions.
• The need for increased awareness and understanding of Type 1 diabetes.

Related pages

• Type 1 diabetes
• Insulin
• Diabetes advocacy